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Abstract: More than 40% of the World population is at risk of contracting malaria,  
which affects primarily poor populations in tropical and subtropical areas. Antimalarial 
pharmacotherapy has utilised plant-derived products such as quinine and artemisinin as 
well as their derivatives. However, worldwide use of these antimalarials has caused the 
spread of resistant parasites, resulting in increased malaria morbidity and mortality. 
Considering that the literature has demonstrated the antimalarial potential of triterpenes, 
specially betulinic acid (1) and ursolic acid (2), this study investigated the antimalarial 
activity against P. falciparum chloroquine-sensitive 3D7 strain of some new derivatives of 1 
and 2 with modifications at C-3 and C-28. The antiplasmodial study employed flow 
cytometry and spectrofluorimetric analyses using YOYO-1, dihydroethidium and 
Fluo4/AM for staining. Among the six analogues obtained, compounds 1c and 2c showed 
excellent activity (IC50 = 220 and 175 nM, respectively) while 1a and b demonstrated good 
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activity (IC50 = 4 and 5 μM, respectively). After cytotoxicity evaluation against HEK293T 
cells, 1a was not toxic, while 1c and 2c showed IC50 of 4 μM and a selectivity index (SI) 
value of 18 and 23, respectively. Moreover, compound 2c, which presents the best 
antiplasmodial activity, is involved in the calcium-regulated pathway(s).  
Keywords: triterpenes; betulinic acid; ursolic acid; malaria; P. falciparum; cytotoxicity; 
calcium 
 
1. Introduction 
Malaria is responsible for some 216 million clinical cases and 655,000 deaths annually, especially 
among children and pregnant women [1]. Due to the spread of resistant parasites, the development of 
new medicines is imperative for the control and eradication of malaria [2].  
Among the first antimalarial substances, the cinchona alkaloids (such as quinine and quinidine) 
were shown to arrest the development of malignant tertian malaria parasites. Subsequently, the 
sesquiterpene lactone artemisinin was obtained from Artemisia annua, and became very important for 
the control of malarial infection, resulting in the development of more potent derivatives, such as 
artemether and artesunate [3]. Thus the partnership between medicinal and natural products chemistry 
is an important strategy in innovative drug discovery [4,5]. In this sense, the chemical modification of 
natural products having antimalarial activities may be one promising method for developing more 
effective and less toxic antimalarial drugs. 
Many studies regarding triterpenes and their derivatives possessing antimalarial activity which 
highlight two triterpenes, betulinic and ursolic acids, are reported [6–10]. For example, Ziegler and  
co-workers described the anti-Plasmodium activity on the 3D7 strain of betulinic acid and its 
analogues and reported that treatment with these compounds resulted in modified erythrocyte 
membranes. While betulinic acid was active, with an IC50 value of 13.9 µM, the most active analogue 
was methyl betulinate (IC50 7 µM) [7]. However, in a murine malarial model of P. berghei betulinic 
acid was ineffective at 250 mg/kg/day [6]. We developed some piperazinyl derivatives of ursolic acid 
obtaining three antimalarial compounds potent against the P. falciparum chloroquine-sensitive Thai 
strain, including compound 2c possessing an IC50 value of 167 nM [10] (Figure 1). Moreover, we 
could demonstrate the importance of the triterpene skeleton bearing an acetyl group at C-3 and the 
piperazine moiety was also identified as a pharmacophore. 
These derivatives were designed based on studies reporting that piperazine derivatives have 
antimalarial action [11,12]. For example, a series of bisacridine derivatives coupled with 
bisaminopropylpiperazine were found to have significant antimalarial effects when tested in vitro for 
antimalarial activity against the P. falciparum chloroquine-resistant FcB1R strain [11].
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Figure 1. Strategy used to obtain N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-
acetylursolamide derivatives as antimalarial agents.  
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Until the moment little is known about mechanism of action for triterpenes, with reports for 
hematin and modification at erythrocyte membrane actions. [7,10]. Because Ca
2+
 homeostasis and 
signalling are fundamental for parasite survival [13–15], the mechanism involved in calcium 
homeostasis within malaria parasites has been investigated as a potential target against malaria [16]. 
In continuation of our research, the present study investigated new piperazinyl derivatives at C-28 
of acetyl betulinic acid (compounds 1a–c) comparing them with those of the ursolic acid (compounds 
2a–c) as prototypes for new antimalarial compounds against the P. falciparum chloroquine-sensitive 
3D7 strain. Further the cytotoxicity in vitro was estimated and a novel antimalarial mechanism of 
action for triterpenes was also revealed.  
2. Results and Discussion 
2.1. Chemical Synthesis 
After being isolated from natural sources, the importance of the C-3 hydroxyl group of betulinic and 
ursolic acids 1 and 2 was ascertained through usual acetylation (Scheme 1). The acetylated compounds 
numbered 1a and 2a were obtained in 98% yield. The coupling reaction of 1a and 2a with N-tert-
butoxycarbonyl-1,4-bis(3-aminopropyl)piperazine occurred following activation of the carboxylic acid 
at C-17 with oxalyl chloride as previously described [10]. The corresponding derivatives 1b and 2b 
were then isolated in 80% yield. Treatment with 10% trifluoroacetic acid/dichloromethane removed 
the tert-butoxycarbonyl (Boc) to provide compounds 1c and 2c in 70% yield (Scheme 1). All 
compounds were fully characterised by spectroscopic data.  
2.2. Antiplasmodial Assay 
All compounds were evaluated in vitro against the P. falciparum chloroquine-sensitive 3D7 strain 
in comparison to chloroquine which IC50 value was 29 nM. Compound 1 showed moderate activity 
(IC50 18 µM) and 2 was inactive (IC50 36 µM) (Figure 2, Table 1) which results are in agreement with 
those of the literature [6,17,18]. 
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Acetylated derivatives 1a and 2a showed better antimalarial activity than their aglycones (IC50 
values of 4 and 14 µM, respectively) (Figure 2, Table 1). The highest values were obtained for the 
piperazinyl derivatives 1c (IC50 220 nM) and 2c (IC50 175 nM). Protected compounds 1b and 2b 
presented IC50 values of 5 and 15 µM, respectively, demonstrating a lower capacity to reduce 
parasitemia in comparison to unprotected compounds. As shown in Figure 2, the piperazine group 
contributed to a significant improvement in activity as also reported [19]. 
Scheme 1. Synthesis of N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-acetyl betulinamides 
1a–c and N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-acetylursolamides 2a–c.  
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Reagents and conditions: (i) pyridine, acetic anhydride, RT, 24 h; (ii) ClCOCOCl, 0 °C, 3 h; TEA, 
N-tert-butoxycarbonyl-1,4-bis(3-aminopropyl)piperazine, RT, 24 h; (iii) TFA 10%/CH2Cl2, RT, 6 h. 
2.3. Cytotoxicity Assay 
The active derivatives 1a–c and 2c were evaluated for their cytotoxicity in human embryonic 
kidney cells (HEK293T) by monitoring the number of living cells at the same concentrations used to 
evaluate the antiplasmodial activity (100, 10, 1, 0.1, 0.01 and 0.001 µM). Many research groups have 
tried to find cytotoxicity activity from triterpenoids, including betulinic acid and their derivatives. 
Thibeault et al. presented cytotoxicity results of lupane-type triterpenoid glyceryl esters. Betulinic acid 
showed values of 18 to 57 µM in several cell lines [20]. 
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Figure 2. Drug concentration response curves of betulinic and ursolic acid acetylated 
derivatives 1a and 2a, coupled 1b and 2b and deprotected piperazinyl derivatives 1c and  
2c against the chloroquine-sensitive P. falciparum strain 3D7 strain. The results are 
representative of three independent experiments (n = 3).  
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Table 1. Antiplasmodial and cytotoxic activity of compounds 1, 1a–c and 2, 2a–c. The 
results are representative of three independent experiments (n = 3). 
Compounds 
IC50 (µM) 
P. falciparum 3D7 
IC50 (µM) 
HEK293T 
Selectivity Index (SI) 
48 h 
24 h 48 h 
1 
1a 
1b 
1c 
2 
2a 
2b 
2c 
18 
4 
5 
0.220 
36 
14 
15 
0.175 
- 
>100 
4 
4 
- 
- 
- 
4 
- 
>100 
4 
4  
- 
- 
- 
4 
- 
- 
0.8 
18 
- 
- 
- 
23 
On the other hand, the cytotoxicity of heterocyclic triteprenoids derived from betulin and betulinic 
acid was tested against seven tumor and two normal fibroblast cell lines showing activity values from 
1.0 to 55.5 µmol/L [21]. The results displayed in Table 1 show that 1a was not cytotoxic at the tested 
concentrations, while the piperazinyl derivatives 1b, c and 2c showed IC50 values of 4 µM. Moreover, 
the most active compounds 1c and 2c presented SI values of 18 and 23, respectively, being considered 
non-toxic. 
2.4. Infected Erythrocytes: Loading with the Calcium Indicator Fluo4/AM 
Like most eukaryotic cells, malaria parasites have internal Ca
2+ 
pools responsible for regulation of 
signalling processes during invasion, maturation and division that can be mobilised upon agonist 
stimulation in the plasma membrane [22]. The effect of compound 2c through modulation of one or 
more calcium pathways in P. falciparum (3D7) was demonstrated using the fluorescent calcium probe 
Fluo4/AM. This molecule was chosen because it has the highest selectivity index (23, Table 1).  
The typical rise in cytosolic calcium in isolated parasites after addition of compound 2c (100 µM) 
and thapsigargin (THG) (10 µM) is presented in Figure 3a–c. Because THG has been known to 
modulate Ca
2+
 via inhibition of sarco-endoplasmatic reticulum Ca
2+
 ATPase (SERCA) [23], it was 
used as the control in this experiment. The control experiment (with methanol addition) showed clearly 
that the solvent did not elicit calcium increase within the parasites (Figure 3a). On the contrary, when 
THG was added after compound 2c, the calcium increase was greater than the conventional calcium 
mobilisation observed with the control one (Figure 3b). These results indicated that 2c can modulate 
parasite calcium homeostasis. 
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Figure 3. Modulation of the Plasmodium calcium pathway(s) involved in the mechanism 
of action of compound 2c. Representative traces of the change in Fluo4/AM) fluorescence 
over time upon addition of solvent (a) or 2c (100 µM) (b) in P. falciparum followed by 
THG (10 µM) addition. (c) Bar graph analysis of Ca
2+
 concentrations in Fluo4/AM-labelled 
P. falciparum isolated parasites (10
8
 cells mL
−1
) after addition of 2c (100 µM). Data 
presented (104.9 a.u. ± 13.65, n = 9, P = 0.0004) were in P. falciparum. P values (*) were 
calculated by comparison with methanol (0.05%) (1.46 a.u. ± 0.057, n = 4). Bars represent 
the means and SEM values. The fluorescence was measured continuously (acquisition every 
0.5 s). The results are representative of three independent experiments performed in triplicate.  
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3. Experimental  
3.1. General 
Infrared spectra (IR) were obtained using a PerkinElmer FT-IR System Spectrum BX instrument. 
1
H and 
13
C-NMR spectra were recorded on Varian Inova 300 and Varian VNMRS 300 spectrometers 
using TMS as internal standard. Chemical shifts are reported in parts per million (δ). An UltrOTOF 
(BrukerDaltonics) mass spectrometer was used to obtain HR-EI-MS spectra. Melting points were 
determined using a Koffler instrument. All reactions were monitored by thin-layer chromatography on 
Merck silica plates GF using different solvent systems. Column chromatography was carried out on 
silica gel GF (Merck, 60–230 mesh) using gradient mixtures (CH2Cl2/methanol). All reagents were 
purchased as analytical grade. All solvents were dried and distilled prior use. Dichloromethane was 
dried over CaCl2 for 24 h then was submitted to reflux.  
3.2. Plant Material and Isolation of Triterpenes 
The betulinic acid was obtained from Platanus acerifolia. A voucher specimen (ICN 182537) is on 
deposit in the Botany Department Herbarium of Universidade Federal do Rio Grande do Sul, Porto 
Alegre, Brazil. The peel of Malus domestica was a byproduct from the juice industry company 
Tecnovin S.A., Vacaria, RS, Brazil, and was used to obtain the ursolic acid. Both powdered dried 
materials were separately subjected to reflux with ethanol 60% (250 mL, 2 h). Then, after removing 
the ethanol under vacuum, each residual aqueous phase was separately extracted with ethyl acetate, 
and the organic phase was evaporated to dryness to obtain a residue that was submitted to 
recrystallisation. The betulinic acid was recrystallized from methanol, while ursolic acid was 
recrystallized using acetonitrile. Betulinic acid (1). Yield 1.5%. Its structure was confirmed by 
spectroscopic methods which were in agreement with literature data [6,7]. Ursolic acid (2). Yield 4%. 
Its structure was confirmed by spectroscopic methods and literature data [10].  
3.3. Chemical Synthesis 
The ursolic acid derivatives were prepared using a semisynthetic route developed by Gnoatto  
and co-workers which details of the chemistry and structural elucidation were described  
previously [10]. Briefly, the acetylated ursolic acid 2a was submitted to a coupling reaction with  
N-Boc-bisaminopropylpiperazine in basic conditions to obtain 2b, and then the deprotected analogue 
2c was obtained by removing the N-Boc-amino group. All structural assignments were compared with 
the published data [10]. The betulinic acid derivatives were obtained using an analogous route.  
3-O-Acetylbetulinic acid (1a). Yield 98%. It was prepared from the corresponding aglycone 1 by usual 
acetylation [10].  
N-{3-[4-(3-Aminopropyl)piperazinopropyl]terbutylcarbamate}-3-acetylbetulinamide (1b). Oxalyl chloride 
(0.15 mL, 1.7 mmol) was added to 1a (285 mg, 0.57 mmol) dissolved in CH2Cl2 (30 mL) at 0 °C, and the 
resulting solution was stirred under N2 for 3 h. Subsequently, triethylamine (0.5 mL, 3.4 mmol) and then 
tert-butyl 3-[4-(3-aminopropyl)piperazinylpropyl]carbamate (510 mg, 1.7 mmol) were added to the 
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reaction, which was then stirred for 24 h at room temperature. Next, water was added and the resulting 
product was extracted with CH2Cl2 (3 × 30 mL); the organic layers were combined, dried over Na2SO4 
and evaporated under vacuum to afford 1b as a white solid. Yield: 80%; m.p. 129 °C; IR (ATR cm
−1
): 
3406 (NH); 2943 (C-H); 1777 (C=O acetyl); 1687 (C=O amide); 1555 (C=C); 1425 (C-O); 1380 (C-H); 
1259 (C-O-C); 1176 (C-N). 
1
H-NMR (CDCl3, δ): 0.84 (s, 3H, H26); 0.85 (s, 3H, H27); 0.87 (s, 3H, H25); 
0.95 (s, 3H, H23); 0.97 (s, 3H, H24); 1.29 (d, 4H, H11, H12); 1.38 (m, 3H, H6, H9); 1.45 (s, 9H, H3C-Boc); 
1.55 (t, 4H, H15, H7); 1.65 (m, 6H, H13, 2 × CH2, H5); 1.69 (s, 3H H30); 1.76 (t, 4H, H16, H1) 1.97 (t, 
3H, H18, H2); 2.04 (s, 3H, H3C-COO-); 2.47 (m, 15H, H1, 7 × CH2); 3.19 (m, 2H, CH2); 3.32 (m, 4H,  
2 × CH2); 4.48 (dd, 1H, H3); 4.59 (brs,1H, H29a); 4.75 (brs, 1H, H29b); 5.36 (1H, NH); 6.86 (1H, NH). 
13
C-NMR (CDCl3, δ): 14.55; 16.14; 16.22; 16.43; 18.17; 19.46; 20.94; 20.20; 23.68; 21.22 (H3C-COO-); 
25.57; 26.42; 28.41 (H3C-Boc); 29.41; 30.91; 33.84; 34.93; 37.12; 37.58; 37.77; 38.39; 38.46; 39.55; 
39.87; 40.76; 42.42; 46.68; 50.20; 50.57; 53.10; 53.45; 55.48 (4C); 56.73; 57.85; 75.80; 78.79 (Cq-Boc); 
80.93; 109.23; 151.04; 156.0 (CO-Boc); 170.90 (H3C-COO-); 176.14 (C-28). HRMS (ESI-MS, m/z); 
[M+H]
+
: Calcd. for C47H80N4O5: 781.1619; Found: 781.6175.  
N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-acetylbetulinamide (1c). The N-Boc-amino protecting 
group of compound 1b was removed using trifluoroacetic acid 10%/dichloromethane mixture 
according to the literature [10], resulting in the deprotected analogue 1c. Yield 70%; m.p. 120 °C. Its 
spectroscopic data were similar to those of 1b, excepting for the absence of the N-Boc-amino signals. 
HRMS (ESI-MS, m/z), [M+H]
+
: Calcd. for C40H72N4O3: 681.0461; Found: 681.5712.  
3.4. Antiplasmodial Assay 
The chloroquine-sensitive 3D7 strain of P. falciparum was grown in RPMI (Gibco/Life 
Technologies, Grand Island, NY, USA) containing 37.5 mM HEPES, supplemented with 7 mM D-glucose, 
6 mM NaOH, 25 mL gentamicin sulphate, 2 mM L-glutamine and 10% human serum albumin. The 
strains were maintained in human erythrocytes in a gas mixture containing 5% O2, 5% CO2 and 90% 
N2 [24]. The culture was synchronised by 10% sorbitol treatment [25]. The antimalarial activity was 
measured using the microdilution technique in vitro. Red cells with parasitemia between 1–2% and 2% 
hematocrit were incubated with the compounds 1, 1a–c and 2, 2a–c for 48 h. Samples were dissolved 
in water, dimethylsulfoxide (DMSO) or methanol and serially diluted with the culture medium. To 
evaluate parasitemia, Giemsa staining and flow cytometric analysis were used. The concentration of 
the drug required to inhibit parasite growth was determined by comparing the fluorescence incorporated 
into the treated and untreated cultures (control). The concentration causing 50% inhibition (IC50) was 
determined from the drug concentration response curve. Methanol and DMSO were used at the 
maximum concentration of 0.1% and did not inhibit parasite growth. 
3.5. Cytotoxicity Assay 
Human embryonic kidney (HEK293T) cells were cultured in surface area 75 cm
2
 (Greiner Bio-One, 
Frickenhausen, Germany) vented tissue culture flasks at 37 °C in a humidified atmosphere containing 
5% CO2 in Dulbecco’s modified essential medium (Gibco/Life Technologies, Grand Island, NY, USA) 
supplemented with 10% (v/v) foetal bovine serum, 100 U/mL penicillin and 100 µg/mL streptomycin. 
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After 24 h, 50 µL of each drug was added with 0.5% DMSO or methanol to a single well. The cells 
were incubated with the test drugs for an additional 24 and 48 h and then harvested with trypsin, gently 
pelleted by centrifugation and re-suspended in PBS. The cells were stained with dihydroethidium 
solution (10 mg/mL in phosphate buffered saline), gently vortexed and incubated for 40 min at 37 °C in 
the dark. Ten thousand gated events were acquired for each sample (FACSCalibur BD and CellQuest 
software was used for analysis). 
3.6. Infected Erythrocytes: Loading with the Calcium Indicator Fluo4/AM  
Erythrocytes (RBCs) infected by P. falciparum (3D7) at the trophozoite stage were lysed with  
10 mg/mL saponin (in phosphate-buffered saline) in the presence of 20 µg/mL protease inhibitors 
(pepstatin A, leupeptin, antipain and chymostatin) and benzamidine (0.5 mmol/L). Erythrocyte 
membranes were then removed through centrifugation (8700 rpm for 10 min at 4 °C). The parasites 
were washed three times in buffer M (116 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 5.5 mM D-glucose, 
50 mM MOPS, pH 7.3) with CaCl2 (2 mM). The parasites were then re-suspended in the same buffer 
with Fluo4-AM (5 μM) probenecid (1.8 mM), an inhibitor of organic anion transport (to prevent dye 
sequestration and release), 20 mg/mL protease inhibitors (pepstatin A, leupeptin, antipain and 
chymostatin) and benzamidine (0.5 mmol/L) for 50 min at 37 °C. The parasite suspension was then 
washed three times with buffer M. Spectrofluorimetric measurements were performed in a Shimadzu 
RF-5301 PC instrument at 37 °C with isolated P. falciparum (3D7) parasites (10
8
 cells mL
−1
) 
incubated with MOPS buffer in a 1 mL cuvette. Compound 2c (100 μM) and THG (10 μM) were 
added during time course experiments, and excitation/emission wavelengths were adjusted to 505/530 nm 
for Fluo4-AM. Methanol (0.05%) was used as a control. Addition of the detergent digitonin induced 
the maximum increase in calcium that was abolished by addition of the calcium chelator EGTA. 
3.7. Statistical Analysis 
Student’s test was chosen for comparisons between two groups, whereas repeated ANOVA 
measures were used for comparisons among more than two groups. The results are expressed as the 
mean ± SEM of at least three individual experiments. P < 0.05 was considered a statistically 
significant difference. GraphPad Prism software (San Diego, CA) was used for all statistical tests. 
4. Conclusions 
In this study, we synthesized new piperazinyl derivatives of betulinic and ursolic acids considering 
the previous active designed compounds. The best compounds, 1c and 2c, showed IC50 values in the 
range of 175 to 220 nM against the P. falciparum chloroquine-sensitive 3D7 strain, and they are 
considered non-toxic (SI > 10 μM). The observed changes in calcium homeostasis demonstrated that 
ursolic acid derivative 2c led to an increase in intracellular ion concentrations in P. falciparum.  
In conclusion, compound 2c is a new potent antimalarial prototype that disrupts Plasmodium  
calcium homeostasis.  
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